The U.S. Food and Drug Administration (FDA) has given 510(k) clearance to Sonavex for its EchoSure™ ultrasound blood flow measuring system. EchoSure combines three-dimensional (3D) ultrasound imaging with advanced deep learning algorithms to automate visual and quantitative blood flow monitoring after surgery.
When combined with its EchoMark® bioresorbable markers, EchoSure eliminates the need for ultrasound expertise in order to measure blood flow, according to Baltimore-headquartered Sonavex. An EchoSure App enables surgeons to monitor patients remotely from mobile devicesBack To Top
FDA clears Sonavex EchoSure portable ultrasound. Appl Radiol.